spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Dario 

 HSMN NewsFeed - 29 Jul 2022
Novasenta Completes $40 million Series A to Advance Novel Cancer Therapeutics
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 8 Dec 2020
Amgen's Sotorasib Granted Breakthrough Therapy Designation for Advanced or Metastatic Non-Small Cell Lung Cancer Patients with KRAS G12C Mutation
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 26 Mar 2018
DarioHealth Receives U.S. FDA Clearance for iPhone 7, 8 and iPhone X Smart Glucose Meter
Devices Monitoring Endocrinology FDA
 HSMN NewsFeed - 18 Oct 2017
DarioHealth Gains CE Mark for iPhone 7 and iPhone 8 Smart Glucose Meter
Devices Monitoring Endocrinology Regulatory
 HSMN NewsFeed - 27 Jan 2017
Juno Therapeutics Appoints Corsee D. Sanders as Executive Vice President and Head of Development Operations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 21 Jul 2016
LabStyle Innovations Corp. Executes Distribution Partnership with GEMCO Medical
Devices Monitoring Distribution
 HSMN NewsFeed - 22 Dec 2015
LabStyle Innovations Receives U.S. FDA Marketing Clearance for the Dario Blood Glucose Monitoring System
Devices Monitoring Endocrinology FDA
 HSMN NewsFeed - 7 Apr 2014
Merck Serono Announces Initiation of Phase III START2 Study with Tecemotide in Stage III Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Feb 2014
LabStyle Innovation Signs Agreement with uHealth to Exclusively Distribute the Dario(TM) Blood Glucose Monitoring Device in Australia
Devices Monitoring Endocrinology Distribution
 HSMN NewsFeed - 16 Oct 2012
Clinical Study Validates Sequenta’s LymphoSIGHT(TM) Platform as More Sensitive Alternative to Flow Cytometry for Cancer Detection
Diagnostics Oncology
 HSMN NewsFeed - 26 Jan 2011
Teva to Acquire Corporación Infarmasa
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Jul 2007
Spectrum Pharmaceuticals Acquires From Indena Worldwide Rights To Ortataxel, A Phase 2 Third Generation Taxane
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 19 Apr 2007
Antares Pharma Announces Positive Results from Application Site Study for ANTUROL(R)
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 26 Jun 2006
Antares Reports On End of Phase II Meeting with FDA for Anturol(TM)
Biopharmaceuticals Urology
Return to NewsFeed  

 Additional items found! 6

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 6 additional stories matching:
Dario
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.